{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:32:45Z","timestamp":1783567965996,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis is a rare autoimmune condition leading to incurable complications. Therefore fast and precise diagnosis is crucial to prevent patient death and to maintain quality of life. Unfortunately, currently known biomarkers do not meet this need. To address this problem researchers use diverse approaches to elucidate the underlying aberrations. One of the methods applied is metabolomics. This modern technique enables a comprehensive assessment of multiple compound concentrations simultaneously. As it has been gaining popularity, we found it necessary to summarize metabolomic studies presented so far in a narrative review. We found 11 appropriate articles. All of the researchers found significant differences between patients and control groups, whereas the reported findings were highly inconsistent. Additionally, we have found the investigated groups in most studies were scarcely described, and the inclusion\/exclusion approach was diverse. Therefore, further study with meticulous patient assessment is necessary.<\/jats:p>","DOI":"10.1007\/s00296-024-05628-y","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:01:52Z","timestamp":1720551712000},"page":"1813-1822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolomics in systemic sclerosis"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7233-0215","authenticated-orcid":false,"given":"Zuzanna","family":"Gogulska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9786-693X","authenticated-orcid":false,"given":"Zaneta","family":"Smolenska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-0214","authenticated-orcid":false,"given":"Jacek","family":"Turyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8889-697X","authenticated-orcid":false,"given":"Zbigniew","family":"Zdrojewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-8786","authenticated-orcid":false,"given":"Micha\u0142","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"5628_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CLEP.S191418","volume":"11","author":"A Bergamasco","year":"2019","unstructured":"Bergamasco A, Hartmann N, Wallace L, Verpillat P (2019) Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin Epidemiol 11:257\u2013273. https:\/\/doi.org\/10.2147\/CLEP.S191418","journal-title":"Clin Epidemiol"},{"issue":"7","key":"5628_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","volume":"15","author":"M Cutolo","year":"2019","unstructured":"Cutolo M, Soldano S, Smith V (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol 15(7):753\u2013763. https:\/\/doi.org\/10.1080\/1744666X.2019.1614915","journal-title":"Expert Rev Clin Immunol"},{"key":"5628_CR3","doi-asserted-by":"publisher","unstructured":"Gwinutt JM, Wieczorek M, Balanescu A et al (2023) 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis 82:48\u201356 https:\/\/doi.org\/10.1136\/annrheumdis-2021-222020","DOI":"10.1136\/annrheumdis-2021-222020"},{"key":"5628_CR4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/1756-185X.13353","volume":"21","author":"L Gupta","year":"2018","unstructured":"Gupta L, Ahmed S, Jain A, Misra R (2018) Emerging role of metabolomics in rheumatology. Int J Rheum 21:1468\u20131477. https:\/\/doi.org\/10.1111\/1756-185X.13353","journal-title":"Int J Rheum"},{"key":"5628_CR5","doi-asserted-by":"publisher","unstructured":"Jacob M, Lopata AL, Dasouki M, Abdel Rahman AM (2019) Metabolomics toward personalized medicine. Mass Spectrom Rev 38:221\u2013238 https:\/\/doi.org\/10.1002\/mas.21548","DOI":"10.1002\/mas.21548"},{"key":"5628_CR6","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, Guo AC, Oler E et al (2022) HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res 50:D622\u2013D631. https:\/\/doi.org\/10.1093\/nar\/gkab1062","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"5628_CR7","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1021\/acs.jproteome.0c00179Dsd","volume":"19","author":"\u00c1 Fern\u00e1ndez-Ochoa","year":"2020","unstructured":"Fern\u00e1ndez-Ochoa \u00c1, Brunius C, Borr\u00e1s-Linares I et al (2020) Metabolic disturbances in urinary and plasma samples from seven different systemic autoimmune diseases detected by HPLC-ESI-QTOF-MS. J Proteome Res 19(8):3220\u20133229. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00179Dsd","journal-title":"J Proteome Res"},{"issue":"7","key":"5628_CR8","doi-asserted-by":"publisher","first-page":"e0159384","DOI":"10.1371\/journal.pone.0159384","volume":"11","author":"AA Bengtsson","year":"2016","unstructured":"Bengtsson AA, Trygg J, Wuttge DM et al (2016) Metabolic profiling of systemic lupus erythematosus and comparison with primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis. PLoS ONE 11(7):e0159384. https:\/\/doi.org\/10.1371\/journal.pone.0159384","journal-title":"PLoS ONE"},{"key":"5628_CR9","doi-asserted-by":"publisher","unstructured":"Guo M, Liu D, Jiang Y et al (2023) Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis. Metabolism 144:155587 https:\/\/doi.org\/10.1016\/j.metabol.2023.155587","DOI":"10.1016\/j.metabol.2023.155587"},{"key":"5628_CR10","doi-asserted-by":"publisher","unstructured":"Meier C, Freiburghaus K, Bovet C et al (2020) Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease. Sci Rep 14;10(1):21912 https:https:\/\/doi.org\/10.1038\/s41598-020-78951-6","DOI":"10.1038\/s41598-020-78951-6"},{"key":"5628_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10067-022-06372-z","volume":"42","author":"C Sun","year":"2023","unstructured":"Sun C, Zhu H, Wang Y et al (2023) Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis. Clin Rheumatol 42:125\u2013134. https:\/\/doi.org\/10.1007\/s10067-022-06372-z","journal-title":"Clin Rheumatol"},{"key":"5628_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/nyas.13736","volume":"1421","author":"C Bellocchi","year":"2018","unstructured":"Bellocchi C, Fern\u00e1ndez-Ochoa \u00c1, Montanelli G et al (2018) Microbial and metabolic multi-omic correlations in systemic sclerosis patients. Ann N Y Acad Sci 1421:97\u2013109. https:\/\/doi.org\/10.1111\/nyas.13736","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"5628_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/biomedicines10030607","volume":"10","author":"T B\u00f6gl","year":"2022","unstructured":"B\u00f6gl T, Mlynek F, Himmelsbach M et al (2022) Plasma metabolomic profiling reveals four possibly disrupted mechanisms in systemic sclerosis. Biomedicines 10(3):607. https:\/\/doi.org\/10.3390\/biomedicines10030607","journal-title":"Biomedicines"},{"key":"5628_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fimmu.2020.00822","volume":"11","author":"A Ottria","year":"2020","unstructured":"Ottria A, Hoekstra AT, Zimmermann M et al (2020) Fatty acid and carnitine metabolism are dysregulated in systemic sclerosis patients. Front Immunol 11:822. https:\/\/doi.org\/10.3389\/fimmu.2020.00822","journal-title":"Front Immunol"},{"key":"5628_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpba.2018.09.021","volume":"162","author":"\u00c1 Fern\u00e1ndez-Ochoa","year":"2019","unstructured":"Fern\u00e1ndez-Ochoa \u00c1, Quirantes-Pin\u00e9 R, Borr\u00e1s-Linares I et al (2019) Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients. J Pharm Biomed Anal 162:82\u201390. https:\/\/doi.org\/10.1016\/j.jpba.2018.09.021","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"5628_CR16","doi-asserted-by":"publisher","first-page":"7627","DOI":"10.1038\/s41598-018-25992-7","volume":"8","author":"F Murgia","year":"2018","unstructured":"Murgia F, Svegliati S, Poddighe S et al (2018) Metabolomic profile of systemic sclerosis patients. Sci Rep 8(1):7627. https:\/\/doi.org\/10.1038\/s41598-018-25992-7","journal-title":"Sci Rep"},{"key":"5628_CR17","doi-asserted-by":"publisher","unstructured":"Smolenska Z, Zabielska-Kaczorowska M, Wojteczek A, Kutryb-Zajac B, Zdrojewski Z (2020) Metabolic Pattern of Systemic Sclerosis: Association of Changes in Plasma Concentrations of Amino Acid-Related Compounds With Disease Presentation. Front Mol Biosci 7:585161 https:\/\/doi.org\/10.3389\/fmolb.2020.585161","DOI":"10.3389\/fmolb.2020.585161"},{"issue":"1","key":"5628_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.chest.2022.08.2230","volume":"163","author":"M Alotabi","year":"2023","unstructured":"Alotabi M, Shao J, Pauciulo MW et al (2023) Metabolomic profiles differentiate Scleroderma-PAH from idiopathic PAH and correspond with worsened functional capacity. Chest 163(1):204\u2013215. https:\/\/doi.org\/10.1016\/j.chest.2022.08.2230","journal-title":"Chest"},{"key":"5628_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ijcard.2017.04.024","volume":"241","author":"M Deidda","year":"2017","unstructured":"Deidda M, Piras C, Cadeddu Dessalvi C et al (2017) Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension. Int J Cardiol 241:401\u2013406. https:\/\/doi.org\/10.1016\/j.ijcard.2017.04.024","journal-title":"Int J Cardiol"},{"issue":"5","key":"5628_CR20","doi-asserted-by":"publisher","first-page":"L617","DOI":"10.1152\/ajplung.00177.2023","volume":"325","author":"CE Simpson","year":"2023","unstructured":"Simpson CE, Ambade AS, Harlan R et al (2023) Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 325(5):L617\u2013L627. https:\/\/doi.org\/10.1152\/ajplung.00177.2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"65","key":"5628_CR21","doi-asserted-by":"publisher","first-page":"9852","DOI":"10.1039\/d3an01051a","volume":"59","author":"Q Du","year":"2023","unstructured":"Du Q, Wang X, Chen J et al (2023) Urine and serum metabolic profiling combined with machine learning for autoimmune disease discrimination and classification. Chem Commun (camb) 59(65):9852\u20139855. https:\/\/doi.org\/10.1039\/d3an01051a","journal-title":"Chem Commun (camb)"},{"issue":"18","key":"5628_CR22","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1039\/d3cc01861j","volume":"148","author":"Q Du","year":"2023","unstructured":"Du Q, Wang X, Chen J al (2023) Machine learning encodes urine and serum metabolic patterns for autoimmune disease discrimination, classification and metabolic dysregulation analysis. Analyst 148(18):4318\u20134330. https:\/\/doi.org\/10.1039\/d3cc01861j","journal-title":"Analyst"},{"key":"5628_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","volume":"8","author":"J Park","year":"2015","unstructured":"Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Petterson J, Kim CH (2015) Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8:80\u201393. https:\/\/doi.org\/10.1038\/mi.2014.44","journal-title":"Mucosal Immunol"},{"issue":"1","key":"5628_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15698\/cst2020.01.209","volume":"4","author":"D Cucchi","year":"2019","unstructured":"Cucchi D, Camacho-Mu\u00f1oz D, Certo M, Pucino V, Nicolaou A, Mauro C (2019) Fatty acids - from energy substrates to key regulators of cell survival, proliferation and effector function. Cell Stress 4(1):9\u201323. https:\/\/doi.org\/10.15698\/cst2020.01.209","journal-title":"Cell Stress"},{"issue":"1","key":"5628_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41598-018-37246-7","volume":"9","author":"MCP Cleophas","year":"2019","unstructured":"Cleophas MCP, Ratter JM, Bekkering S, Quintin J, Schraa K, Stroes E, Netea M, Joosten LAB (2019) Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males. Sci Rep 9(1):775. https:\/\/doi.org\/10.1038\/s41598-018-37246-7","journal-title":"Sci Rep"},{"issue":"4","key":"5628_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/S41598-018-37246-7","volume":"43","author":"A Haghikia","year":"2015","unstructured":"Haghikia A, J\u00f6rg S, Duscha A et al (2015) Dietary fatty acids directly Impact Central Nervous System Autoimmunity via the small intestine. Immunity 43(4):817\u2013829. https:\/\/doi.org\/10.1038\/S41598-018-37246-7","journal-title":"Immunity"},{"issue":"1","key":"5628_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/RHEUMATOLOGY\/KEAD208","volume":"63","author":"E Russo","year":"2024","unstructured":"Russo E, Bellando-Randone S, Carboni D et al (2024) The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis. Rheumatology (Oxford) 63(1):226\u2013234. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAD208","journal-title":"Rheumatology (Oxford)"},{"key":"5628_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.06.008","volume":"73","author":"X Ji","year":"2023","unstructured":"Ji X, Wu L, Marion T, Luo Y (2023) Lipid metabolism in regulation of B cell development and autoimmunity. Cytokine Growth Factor Rev 73:40\u201351. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.06.008","journal-title":"Cytokine Growth Factor Rev"},{"key":"5628_CR29","doi-asserted-by":"publisher","first-page":"761721","DOI":"10.3389\/fmolb.2021.761721","volume":"8","author":"Z Gogulska","year":"2021","unstructured":"Gogulska Z, Smolenska Z, Turyn J, Mika A, Zdrojewski Z (2021) Lipid alterations in systemic sclerosis. Front Mol Biosc 8:761721. https:\/\/doi.org\/10.3389\/fmolb.2021.761721","journal-title":"Front Mol Biosc"},{"key":"5628_CR30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J et al (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum 76:1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum"},{"key":"5628_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.freeradbiomed.2022.06.228","volume":"188","author":"T Petan","year":"2022","unstructured":"Petan T, Man\u010dek-Keber M (2022) Half is enough: oxidized lysophospholipids as novel bioactive molecules. Free Radic Biol Med 188:351\u2013362. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.06.228","journal-title":"Free Radic Biol Med"},{"key":"5628_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.biochi.2012.08.006","volume":"95","author":"L Perrin-Cocon","year":"2013","unstructured":"Perrin-Cocon L, Diaz O, Andr\u00e9 P, Lotteau (2013) Modified lipoproteins provide lipids that modulate dendritic cell immune function. Biochimie 95:103\u2013108. https:\/\/doi.org\/10.1016\/j.biochi.2012.08.006","journal-title":"Biochimie"},{"key":"5628_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bcp.2019.02.029","volume":"163","author":"A Garc\u00eda-Mart\u00edn","year":"2019","unstructured":"Garc\u00eda-Mart\u00edn A, Garrido-Rodr\u00edguez M, Navarrete C (2019) Cannabinoid derivatives acting as dual PPAR\u03b3\/CB2 agonists as therapeutic agents for systemic sclerosis. Niochem Pharmacol 163:321\u2013334. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.029","journal-title":"Niochem Pharmacol"},{"key":"5628_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1874312901206010123","volume":"6","author":"BS Shea","year":"2012","unstructured":"Shea BS, Tager AM (2012) Sphingolipid regulation of tissue fibrosis. Open Rheumatol J 6:123. https:\/\/doi.org\/10.2174\/1874312901206010123","journal-title":"Open Rheumatol J"},{"key":"5628_CR35","doi-asserted-by":"publisher","unstructured":"Cartier A, Hla T (21019) Sphingosine 1-phosphate: lipid signaling in pathology and therapy. Science 366(6463):eaar5551. https:\/\/doi.org\/10.1126\/SCIENCE.AAR5551","DOI":"10.1126\/SCIENCE.AAR5551"},{"key":"5628_CR36","doi-asserted-by":"publisher","first-page":"BSR20221682","DOI":"10.1042\/BSR20221682","volume":"42","author":"AAB Badawy","year":"2022","unstructured":"Badawy AAB (2022) Tryptophan metabolism and disposition in cancer biology and immunotherapy. Biosci Rep 42:BSR20221682. https:\/\/doi.org\/10.1042\/BSR20221682","journal-title":"Biosci Rep"},{"key":"5628_CR37","doi-asserted-by":"publisher","first-page":"731701","DOI":"10.3389\/FIMMU.2021.731701","volume":"12","author":"T Ramprasath","year":"2021","unstructured":"Ramprasath T, Han YM, Zhang D, Yu CJ, Zou MH (2021) Tryptophan catabolism and inflammation: a Novel Therapeutic Target for aortic diseases. Front Immunol 12:731701. https:\/\/doi.org\/10.3389\/FIMMU.2021.731701","journal-title":"Front Immunol"},{"key":"5628_CR38","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","volume":"11","author":"A Perl","year":"2015","unstructured":"Perl A, Hanczko R, Lai ZW et al (2015) Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics 11:1157. https:\/\/doi.org\/10.1007\/s11306-015-0772-0","journal-title":"Metabolomics"},{"issue":"2","key":"5628_CR39","doi-asserted-by":"publisher","first-page":"e200012","DOI":"10.20900\/IMMUNOMETAB20200012","volume":"2","author":"P Piranavan","year":"2020","unstructured":"Piranavan P, Bhamra M, Perl A (2020) Metabolic targets for treatment of Autoimmune diseases. Immunometabolism 2(2):e200012. https:\/\/doi.org\/10.20900\/IMMUNOMETAB20200012","journal-title":"Immunometabolism"},{"issue":"Suppl 3","key":"5628_CR40","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.5152\/eurjrheum.2020.19192","volume":"7","author":"BK Mehta","year":"2020","unstructured":"Mehta BK, Espinoza ME, Hinchcliff M, Whitfield ML (2020) Molecular omic signatures in systemic sclerosis. EUR J Rheumatol 7(Suppl 3):S173\u2013S180. https:\/\/doi.org\/10.5152\/eurjrheum.2020.19192","journal-title":"EUR J Rheumatol"},{"key":"5628_CR41","unstructured":"Modified from http:\/\/www.prisma-statement.org\/PRISMAStatement\/FlowDiagram, Accessed 24 February 2024"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05628-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05628-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T02:04:08Z","timestamp":1726193048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05628-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5628"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05628-y","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}